|
1
|
Attele AS, Wu JA and Yuan CS: Ginseng
pharmacology: Multiple constituents and multiple actions. Biochem
Pharmacol. 58:1685–1693. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xiang YZ, Shang HC, Gao XM and Zhang BL: A
comparison of the ancient use of ginseng in traditional Chinese
medicine with modern pharmacological experiments and clinical
trials. Phytother Res. 22:851–858. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang W, Rayburn ER, Hao M, Zhao Y, Hill
DL, Zhang R and Wang H: Experimental therapy of prostate cancer
with novel natural product anti-cancer ginsenosides. Prostate.
68:809–819. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee WM, Kim SD, Kim KS, Song YB, Kwak YS,
Cho JY, Park HJ, Oh JW and Rhee MH: Protopanaxadiol modulates
LPS-induced inflammatory activity in murine macrophage RAW264.7
cells. J Ginseng Res. 30:181–187. 2006. View Article : Google Scholar
|
|
5
|
Hui YZ, Yang ZR, Yang ZQ and Ge Q:
Inventors; CN-KnowHow intellectual property agent limited,
assignee. Antidepressant compositions containing
20(S)-protopanaxadiol extracted from ginsenoside. China Patent CN
200610027507.1. Jan 17–2007.
|
|
6
|
Qi LW, Wang CZ and Yuan CS: American
ginseng: Potential structure-function relationship in cancer
chemoprevention. Biochem Pharmacol. 80:947–954. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li G and Wang Z, Sun Y, Liu K and Wang Z:
Ginsenoside 20(S)-protopanaxadiol inhibits the proliferation and
invasion of human fibrosarcoma HT1080 cells. Basic Clin Pharmacol
Toxicol. 98:588–592. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu GY, Bu X, Yan H and Jia WW:
20S-protopanaxadiol-induced programmed cell death in glioma cells
through caspase-dependent and -independent pathways. J Nat Prod.
70:259–264. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kasai R, Hara K, Dokan R, Suzuki N,
Mizutare T, Yoshihara S and Yamasaki K: Major metabolites of
ginseng sapogenins formed by rat liver microsomes. Chem Pharm Bull
(Tokyo). 48:1226–1227. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li L, Chen X, Li D and Zhong D:
Identification of 20(S)-protopanaxadiol metabolites in human liver
microsomes and human hepatocytes. Drug Metab Dispos. 39:472–483.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu J, Wang X, Liu P, Deng R, Lei M, Chen
W and Hu L: 20(S)-Protopanaxadiol (PPD) analogues chemosensitize
multidrug-resistant cancer cells to clinical anticancer drugs.
Bioorg Med Chem. 21:4279–4287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen G, Liu J, Chen W, Xu Q, Xiao M, Hu L,
Mao L and Wang X: A 20(S)-protopanoxadiol derivative overcomes
multi-drug resistance by antagonizing ATP-binding cassette
subfamily B member 1 transporter function. Oncotarget. 7:9388–9403.
2016.PubMed/NCBI
|
|
13
|
Gurley BJ, Gardner SF, Hubbard MA,
Williams DK, Gentry WB, Cui Y and Ang CY: Cytochrome P450
phenotypic ratios for predicting herb-drug interactions in humans.
Clin Pharmacol Ther. 72:276–287. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Butterweck V and Derendorf H: Herb-drug
interactions. Planta Med. 78:13992012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nelson-Rees WA and Flandermeyer RR: HeLa
cultures defined. Science. 191:96–98. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Capes-Davis A, Theodosopoulos G, Atkin I,
Drexler HG, Kohara A, MacLeod RA, Masters JR, Nakamura Y, Reid YA,
Reddel RR and Freshney RI: Check your cultures! A list of
cross-contaminated or misidentified cell lines. Int J Cancer.
127:1–8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qiu JG, Zhang YJ, Li Y, Zhao JM, Zhang WJ,
Jiang QW, Mei XL, Xue YQ, Qin WM, Yang Y, et al: Trametinib
modulates cancer multidrug resistance by targeting ABCB1
transporter. Oncotarget. 6:15494–15509. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cai Q, Sun H, Peng Y, Lu J,
Nikolovska-Coleska Z, McEachern D, Liu L, Qiu S, Yang CY, Miller R,
et al: A potent and orally active antagonist (SM-406/AT-406) of
multiple inhibitor of apoptosis proteins (IAPs) in clinical
development for cancer treatment. J Med Chem. 54:2714–2726. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jeong HU, Kong TY, Kwon SS, Hong SW, Yeon
SH, Choi JH, Lee JY, Cho YY and Lee HS: Effect of honokiol on
cytochrome P450 and UDP-glucuronosyltransferase enzyme activities
in human liver microsomes. Molecules. 18:10681–10693. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma S, Li X, Dong L, Zhu J, Zhang H and Jia
Y: Protective effect of Sheng-Mai Yin, a traditional Chinese
preparation, against doxorubicin-induced cardiac toxicity in rats.
BMC Complement Altern Med. 16:612016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wienkers LC and Heath TG: Predicting in
vivo drug interactions from in vitro drug discovery data. Nat Rev
Drug Discov. 4:825–833. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vtorushin SV, Khristenko KY, Zavyalova MV,
Perelmuter VM, Litviakov NV, Denisov EV, Dulesova AY and
Cherdyntseva NV: The phenomenon of multi-drug resistance in the
treatment of malignant tumors. Exp Oncol. 36:144–156.
2014.PubMed/NCBI
|
|
23
|
Shi Z, Liang YJ, Chen ZS, Wang XW, Wang
XH, Ding Y, Chen LM, Yang XP and Fu LW: Reversal of
MDR1/P-glycoprotein-mediated multidrug resistance by vector-based
RNA interference in vitro and in vivo. Cancer Biol Ther. 5:39–47.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ren HC, Sun JG, Wang GJ, A JY, Xie HT, Zha
WB, Yan B, Sun FZ, Hao HP, Gu SH, et al: Sensitive determination of
20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: Application
of pharmacokinetic study in rats. J Pharm Biomed Anal.
48:1476–1480. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hasegawa H: Proof of the mysterious
efficacy of ginseng: Basic and clinical trials: metabolic
activation of ginsenosid: Deglycosylation by intestinal bacteria
and esterification with fatty acid. J Pharmacol Sci. 95:153–157.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hao M, Zhao Y, Chen P, Huang H, Liu H,
Jiang H, Zhang R and Wang H: Structure-activity relationship and
substrate-dependent phenomena in effects of ginsenosides on
activities of drug-metabolizing P450 enzymes. PLoS One.
3:e26972008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lipshultz SE, Lipsitz SR, Mone SM, Goorin
AM, Sallan SE, Sanders SP, Orav EJ, Gelber RD and Colan SD: Female
sex and higher drug dose as risk factors for late cardiotoxic
effects of doxorubicin therapy for childhood cancer. N Engl J Med.
332:1738–1743. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lanzarini L, Bossi G, Laudisa ML, Klersy C
and Aricò M: Lack of clinically significant cardiac dysfunction
during intermediate dobutamine doses in long-term childhood cancer
survivors exposed to anthracyclines. Am Heart J. 140:315–323. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Silber JH and Barber G: ‘Increased risk of
cardiac dysfunction after anthracyclines in girls’. Med Pediatr
Oncol. 25:130–131. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sorensen K, Levitt G, Sebag-Montefiore D,
Bull C and Sullivan I: Cardiac function in Wilms' tumor survivors.
J Clin Oncol. 13:1546–1556. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sakemi T, Ohtsuka N, Tomiyoshi Y and
Morito F: Sex difference in progression of adriamycin-induced
nephropathy in rats. Am J Nephrol. 16:540–547. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gray SL, Lackey BR, Tate PL, Riley MB and
Camper ND: Mycotoxins in root extracts of American and Asian
ginseng bind estrogen receptors alpha and beta. Exp Biol Med
(Maywood). 229:560–568. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee YN, Lee HY, Chung HY, Kim SI, Lee SK,
Park BC and Kim KW: In vitro induction of differentiation by
ginsenoides in F9 teratocarcinoma cells. Eur J Cancer. 32A:1–1428.
1996.
|
|
34
|
Lee YN, Lee HY, Lee YM, Chung HY, Kim SI,
Lee SK, Park BC and Kim KW: Involvement of glucocorticoid receptor
in the induction of differentiation by ginsenosides in F9
teratocarcinoma cells. J Steroid Biochem Mol Biol. 67:105–111.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee Y, Jin Y, Lim W, Ji S, Choi S, Jang S
and Lee S: A ginsenoside-Rh1, a component of ginseng saponin,
activates estrogen receptor in human breast carcinoma MCF-7 cells.
J Steroid Biochem Mol Biol. 84:463–468. 2003. View Article : Google Scholar : PubMed/NCBI
|
